advertisement
14 Costing studies; pharmacoeconomics (7)
Showing records 1 to 7
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics25018 Shared care in glaucoma: a national study of secondary care lead schemes in England
Vernon SA; Adair A
Eye 2010; 24: 265-269
25460 First-year treatment costs among new initiators of topical prostaglandin analogs
Schmier J K; Covert D W; Robin A L
Clinical Ophthalmology 2009; 3: 637-644
25455 Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
Bergstrom A; Maurel F; Le Pen C; Lamure E; Kent M; Bardoulat I; Berdeaux G
Clinical Ophthalmology 2009; 3: 471-481
25014 The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?
Somner JE; Cavanagh DJ; Wong KK; Whitelaw M; Thomson T; Mansfield D
Eye 2010; 24: 361-363
25419 Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs
Schwartz G F; Tan J; Kotak S
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 555-561
25361 Healthcare charges in patients with glaucoma who undergo laser trabeculoplasty
Pasquale L R; Walt J G; Stern L S; Wiederkehr D; Malangone E; Dolgitser M
Advances in Therapy 2009; 1-13
25066 Association between the use of glaucoma medications and mortality
Stein JD; Newman-Casey PA; Niziol LM; Gillespie BW; Lichter PR; Musch DC
Archives of Ophthalmology 2010; 128: 235-240
